Literature DB >> 3800350

In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.

J L Rummens, B Gordts, H W Van Landuyt.   

Abstract

A hemoglobin-supplemented medium composed of Columbia agar base supplemented with 1% hemoglobin and 1% Polyvitex was used to investigate the in vitro activity of 29 antimicrobial agents against Capnocytophaga species. Clindamycin was the most active agent, with all strains being inhibited by 0.06 microgram/ml or less. Amoxicillin-clavulanic acid and imipenem were the most active among the beta-lactam antibiotics (MIC for 90% of strains tested [MIC90], 0.50 microgram/ml); other very active drugs were BMY 28142, cefpirome, cefotaxime, ceftazidime, and ceftriaxone (MIC90, 0.06 to 0.50 micrograms/ml), although at least one strain showed resistance to each of these antibiotics (MIC, greater than or equal to 16 micrograms/ml). Ciprofloxacin was the most active among the quinolones, with all strains being inhibited by 0.50 microgram/ml. The MICs of the other four drugs ranged from 0.12 to 4 micrograms/ml. Ampicillin, penicillin G, ticarcillin, aztreonam, and temocillin were moderately active (MIC90, 1 to 8 micrograms/ml; MIC range, less than or equal to 0.03 to greater than 128 micrograms/ml). All strains were uniformly resistant to the aminoglycosides, polymyxin B, vancomycin, trimethoprim, and amphotericin B. Three strains produced beta-lactamase. No significant difference was found between the susceptibility of strains isolated from various sources or patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3800350      PMCID: PMC176524          DOI: 10.1128/AAC.30.5.739

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Septicemia due to Capnocytophaga (Bacteroides ocharaceus) in Hodgkin's disease.

Authors:  P C Appelbaum; J O Ballard; M E Eyster
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

2.  Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients.

Authors:  S W Forlenza; M G Newman; A I Lipsey; S E Siegel; U Blachman
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

3.  Capnocytophaga: new genus of gram-negative gliding bacteria. II. Morphology and ultrastructure.

Authors:  S C Holt; E R Leadbetter; S S Socransky
Journal:  Arch Microbiol       Date:  1979-07       Impact factor: 2.552

4.  Studies of the microbiology of periodontosis.

Authors:  M G Newman; S S Socransky; E D Savitt; D A Propas; A Crawford
Journal:  J Periodontol       Date:  1976-07       Impact factor: 6.993

5.  Capnocytophaga septicemia.

Authors:  A A Haulk; A M Sugar; J L Rushing
Journal:  N Engl J Med       Date:  1980-04-17       Impact factor: 91.245

6.  Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis.

Authors:  C Gandola; T Butler; S Badger; E Cheng; S Beard
Journal:  Arch Intern Med       Date:  1980-06

7.  Capnocytophaga ochracea septicemia.

Authors:  P H Gilligan; L R McCarthy; B K Bissett
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

8.  Capnocytophaga: new genus of gram-negative gliding bacteria. I. General characteristics, taxonomic considerations and significance.

Authors:  E R Leadbetter; S C Holt; S S Socransky
Journal:  Arch Microbiol       Date:  1979-07       Impact factor: 2.552

9.  Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization.

Authors:  S S Socransky; S C Holt; E R Leadbetter; A C Tanner; E Savitt; B F Hammond
Journal:  Arch Microbiol       Date:  1979-07       Impact factor: 2.552

10.  Agar medium for use in susceptibility testing of bacteria from human periodontal pockets.

Authors:  C B Walker; T A Niebloom; S S Socransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

View more
  12 in total

1.  Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.

Authors:  A Rosenau; B Cattier; N Gousset; P Harriau; A Philippon; R Quentin
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.

Authors:  Anne Jolivet-Gougeon; Zohreh Tamanai-Shacoori; Laurent Desbordes; Nathalie Burggraeve; Michel Cormier; Martine Bonnaure-Mallet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.

Authors:  D L Roscoe; S J Zemcov; D Thornber; R Wise; A M Clarke
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

4.  Molecular identification of Capnocytophaga spp. via 16S rRNA PCR-restriction fragment length polymorphism analysis.

Authors:  Marilou Ciantar; Hubert N Newman; Michael Wilson; David A Spratt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Novel beta-lactamase from Capnocytophaga sp.

Authors:  J E Foweraker; P M Hawkey; J Heritage; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.

Authors:  A Jolivet-Gougeon; A Buffet; C Dupuy; J L Sixou; M Bonnaure-Mallet; S David; M Cormier
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Bacteremia by multidrug-resistant Capnocytophaga sputigena.

Authors:  J L Gomez-Garces; J I Alos; J Sanchez; R Cogollos
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Characterization of a beta-lactamase found in Eikenella corrodens.

Authors:  J M Lacroix; C Walker
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

9.  In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.

Authors:  G Arlet; M J Sanson-Le Pors; I M Casin; M Ortenberg; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.